Claim CME Credit

WEDNESDAY, MAY 3

8:00 am – 12:00 pm PRE CONGRESS SESSION I
*Additional Registration Fees May Apply.
  W11: Advanced Diabetes Technology Concepts
Chair: George Grunberger, MD
Room: 18A-D
CME Code: 3119
  W21: Hot Topics in Bone Disease in 2017: Building Better Bones
Chairs: Rachel Pessah-Pollack, MD; Daniel L. Hurley, MD
Room: 17B
CME Code: 7351
  W31: Providing Reproductive Endocrine Care in the Office
Chairs: Charles Faiman, MD; Rhoda H. Cobin, MD
Room: 16B
CME Code: 8492
  W41: Leading Edge of Practical Thyroidology
Chair: Mark Lupo, MD
Room: 19
CME Code: 7676
1:00 pm – 5:00 pm PRE CONGRESS SESSION II
*Additional Registration Fees May Apply.
  W12: Advanced Diabetes Technology Skills Practice
Room: 3119
CME Code: 6397
  W22: The Practice of Obesity Medicine in 2017
Chair: Ken Fujioka, MD; W. Timothy Garvey, MD
Room: 19
CME Code: 7145
  W32: Endocrinologist - Surgeon: Critical Collaboration with Case-Based Conversations
Chairs: Mira Milas, MD; Jeffrey Garber, MD
Room: 16B
CME Code: 4555
1:00 pm – 5:30 pm W42: AACE Board Review & MOC Course
Moderator: Pauline M. Camacho, MD
Speaker: Pauline M. Camacho, MD; Elise Brett, MD; Sethu K. Reddy, MD
Room:17B
CME Code:6703
5:30 pm – 7:45 pm

WSS1: Burning Questions about New and Emerging Injectable Therapies for Type 2 Diabetes: A Hot Topics Presentation

Supported by an educational grant from Novo Nordisk

Room: JW Marriott: Lonestar E-H
CME Code: 8770
 

WSS2: A Town Hall Series on Improving Access to PCSK9 Inhibitors: Issues and Recommendations Clinicians (Non-CME)

Supported by Amgen, Inc., Sanofi and Regeneron

Room: Lonestar A-D
CME Code:

THURSDAY, MAY 4

5:15 am – 7:30 am

TSS1: Continuous Glucose Monitoring as the Standard of Care: Clinical Outcomes, Improved Access and Non-Adjunctive Use

Supported by an educational grant from Dexcom
Room: JW Marriott: Lonestar E-H
CME Code:7291
 

TSS2: Current Landscape in Medullary Thyroid Cancer: Update for Clinicians

Supported by an educational grant from Genzyme, A Sanofi Company

Room: JW Marriott: Lonestar A-D
CME Code:9684
6:30 am - 6:00 pm Attendee Registration
7:00 am - 6:00 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am – 8:30 am General Session Announcements
8:30 am – 9:15 am TGS1: "But Why Bone?"
Moderator: Pauline M. Camacho, MD
Speaker: Gerard Karsenty, MD

Room: Ballroom D
CME Code: 1314
9:15 am – 10:00 am TGS2: Precision Medicine for Diabetes: Where Are We?
Moderator: Vivian Fonseca, MD
Speaker: Judith Fradkin, MD


Room: Ballroom D
CME Code: 7161
10:00 am – 11:00 am Young Investigator Poster Session in Exhibit Hall
10:15 am – 11:00 am Product Theaters in the Exhibit Hall (2)
11:05 am - 11:15 am Award Presentations
11:15 am – 12:00 pm TGS3: Diabetes Management: Applications of High Tech Innovations
Moderator: George Grunberger,MD
Speaker: William Tamborlane, MD

Room: Ballroom D
CME Code: 9822
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm Young Investigator ePoster Oral Presentations
12:30 pm – 2:15 pm Women's Luncheon: Female Physicians and the Future of Endocrinology
Moderator: Etie S. Moghissi, MD
Speaker: Ann Danoff, MD


Room: Ballroom E - G
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15pm – 2:00 pm Product Theaters (2) in the Exhibit Hall
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  T11: Different Approach to Obesity in T1D vs. T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard E. Pratley, MD


Room: 19
CME Code: 6550
  T21: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


Room: 17B
  T31: Evolving to Precision Thyroid Cancer Care
Moderator: Steven A. De Jong, MD
Speaker: Matt Ringel, MD


Room: 18CD
CME Code: 8361
  T41: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD
Special Guest: John Kanis, MD


Room: 16A
CME Code: 4973
  T51: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


Room: 16B
CME Code: 3439
  T61: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


Room: 18AB
CME Code: 6987
  T71: Personalized Diabetes Management: Cultural Considerations
Moderator: Jeffrey Mechanick, MD
Speaker: Osama Hamdy, MD;
Shashank Joshi, MD

Room: 17A
CME Code: 5324
3:15pm-3:30pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  T12: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul S. Jellinger, MD


Room: 18AB
CME Code: 8246
  T22: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


Room: 17A
CME Code: 2252
  T32: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


Room: 17B
CME Code: 9260
  T42: Different Approach to Obesity in T1D vs T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard E. Pratley, MD


Room: 19
CME Code: 6358
  T52: Evolving to Precision Thyroid Cancer Care
Moderator: Steven A. De Jong, MD
Speaker:Matt Ringel, MD


Room: 18CD
CME Code: 8175
  T62: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD
Special Guest: John Kanis, MD


Room: 16A
CME Code: 5648
  T72: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


Room: 16B
CME Code: 7613
4:30 pm – 4:45 pm Break
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  T13: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


Room: 18CD
CME Code: 4896
  T23: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


Room: 16A
CME Code: 4492
  T33: Personalized Diabetes Management: Cultural Considerations
Moderator: Jeffrey Mechanick, MD
Speaker: Osama Hamdy, MD;
Shashank Joshi, MD


Room: 16B
CME Code: 9022
  T43: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


Room: 17B
CME Code: 1674
  T53: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


Room: 17A
CME Code: 9313
  T63: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul S. Jellinger, MD


Room: 18AB
CME Code: 9484
  T73: Learning From Legends
Moderator: Sethu Reddy, MD
Speaker: Edward Horton, MD


Room: 19
CME Code: 1626
6:00 pm – 7:00 pm Domestic & International Chapter Receptions
7:15 pm – 9:30 pm

TSS3: Using Insulin - When, Where and How It's Needed: Type 2 Diabetes Treatment in the Modern Age

Supported by an educational grant from Sanofi US

Room:JW Marriott: Lonestar E-H
CME Code: 9563
  TSS4: UPDATES ABOUND! Latest and Greatest in Practical Application of Cardiovascular Outcomes for Diabetes Drugs
Supported by an educational grant from AstraZeneca

Room: JW Marriott: Lonestar A-D
CME Code: 1614

FRIDAY, MAY 5

5:15 am – 7:30 am

FSS1: Standardized Glucose Reporting - The New EKG for Diabetes?

Supported by an educational grant from Abbott

Room: JW Marriott: Lonestar E-H
CME Code: 9519
7:30 am - 6:30 pm Attendee Registration
7:30 am - 6:00 pm CME Station Hours
10:30 am - 3:30 pm Exhibit Hall Hours
8:00 am - 8:15 am Award Presentations
8:20 am – 9:05 am FGS1: Osteoporosis: History of FRAX
Moderator: Steven M. Petak, MD
Speaker: John Kanis, MD


Room: Ballroom D
CME Code: 3955
9:15 am – 12:00 pm IN-DEPTH SYMPOSIA SESSION I
  F11: Heart Failure: The Frequent, Forgotten and Fatal Complication of Type 2 Diabetes
Chair: David Bell, MD
Room: 19
CME Code: 9720
  F21: The Transition Process: Key to Continued Best Endocrine Care
Chairs: Robert Rapaport, MD; Jay Cohen, MD
Room: 16B
CME Code: 9674
  F31: Innovations in Evaluation and Management of Adrenal Diseases
Chair: Karel Pacak, MD
Room: 18A-C
CME Code: 8269
  F41: Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer
Chair: Peter Singer, MD
Supported by the Hossain Gharib, MD Educational Fund

Room: 17
CME Code: 5326
  F51: Practical Issues for Nurse Practitioners/Physician Assistants in an Endocrine Practice
Chairs: W. Reid Litchfield, MD; Sondra O’ Callaghan, PA
Room: 16A
CME Code: 2953
12:00 pm – 2:15 pm Exhibit Hall Break
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm ePoster Oral Presentations
12:30 pm – 2:15 pm Fellows-In-Training Luncheon
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15 pm – 2:00 pm Product Theaters in the Exhibit Hall (2)
2:15 pm – 5:00 pm IN-DEPTH SYMPOSIA SESSION II
  F12: The Diabetic Foot: Clear and Unpleasant Danger
Chairs: Andrew Boulton, MD; David Armstrong, MD
Room: 16B
CME Code: 9674
  F22: State-of-the-Art Treatment of Obesity in Your Practice
Chairs: W. Timothy Garvey, MD; Michael Bush, MD
Room: 17
CME Code: 7807
  F32: Metabolic Bone Disease: What's New in 2017?
Chair: Pauline M. Camacho, MD
Room: 18A-C
CME Code: 2067
  F42: The Aging Patient: Endocrinology for the Ages
Chair: Robert M. Palmer, MD
Room:19
CME Code:9052
  F52: Sustaining Your Endocrine Practice
Chair: Richard Haas, MD
Room: 18D
CME Code: 5679
5:00 pm - 6:00 pm Open Discussion of Alternate Business Models for Endocrine Practices
  F62: Insulin Resistance in Latinos : A Nationwide Epidemic
Chairs: Myriam Allende- Vigo, MD; Valentin Sanchez, MD
In conjunction with SMNE

Room:16A
CME Code:9084
4:30 pm – 6:30 pm Poster-Viewing Wine & Cheese Reception in Exhibit Hall
5:00 pm – 6:15 pm Poster Session in Exhibit Hall
6:15 pm – 7:00 pm Product Theaters
7:00 pm – 9:15 pm

FSS3: Hypoparathyroidism: Evolving Presentation, Incorporating Guidelines and Optimizing Treatment

Supported by an educational grant from Shire

Room: JW Marriott: Lonestar E-H
CME Code: 4151
 

FSS4: Treatment Advances for Challenging Patients with Type 2 Diabetes: The Role of Emerging Insulin Combinations

Supported by an educational grant from Sanofi

Room: JW Marriott: Lonestar A-D
CME Code: 2457

SATURDAY, MAY 6

7:30 am -5:00 pm Attendee Registration
7:30 am -6:00 pm CME Station Hours
9:45 am -1:00 pm Exhibit Hall Hours
8:00 am – 8:10 am Poster Award Presentations
8:10 am – 8:15 am Award Presentation
8:15 am – 9:00 am SGS1: Evolution and Revolution of Radioiodine Refractory Thyroid Cancer
Moderator: Felice Caldarella, MD
Speaker: Steve Sherman, MD


Room: Ballroom D
CME Code: 2522
9:00 am - 9:15 am Award Presentations
9:15 am – 10:00 am SGS2: Advances in Pituitary
Moderator: Susan Samson, MD
Speaker: Anne Klibanski, MD


Room: Ballroom D
CME Code: 9167
9:15 am – 10:00 am SGS3: Select Abstract Oral Presentations I
Moderator: David C. Lieb, MD
AN ASSESSMENT OF EASE OF READABILITY OF ONLINE PATIENT EDUCATION MATERIAL ON THYROID CANCER TREATMENT: NOT SO READABLE AFTERALL
Rashika Bansal, MD

SIX YEAR CLINICAL AND IMAGING FOLLOW UP OF AN OFFICE BASED GENE EXPRESSION CLASSIFIER USED TO MANAGE THYROID NODULES
Brian Michael, MD

22 MONTH REVIEW OF IMMUNE CHECKPOINT INHBITOR ASSOCIATED ENDOCRINE DISORDERS AT A SOUTHERN CALIFORNIA TEACHING HOSPITAL
Lauren Clarine, DO

Room: 17A
CME Code: 8105
9:15 am – 10:00 am SGS4:Select Abstract Oral Presentations II
Moderator: Matthew J. Levine, MD
EFFECTS OF CANAGLIFLOZIN VERSUS GLIMEPIRIDE ON ADIPOKINES, INFLAMMATORY BIOMARKERS, AND CHEMOKINES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
W. Timothy Garvey, MD

CLINICAL PREDICTORS OF PROGRESSION TO INSULIN USE AMONG CHINESE PATIENTS WITH TYPE 2 DIABETES- THE HONG KONG DIABETES REGISTRY
Ronald Ma, MB, BCh.

VALUE OF CHRONIC DISEASE REGISTRY IN EVALUATING PREDICTORS FOR DIABETES-RELATED CLINICAL INERTIA
Wael Eid, MD

Room: 17B
CME Code: 6636
10:00 am – 11:00 am Late Breaking Poster Session in Exhibit Hall
10:15 am – 11:00 am> Product Theaters (2) in the Exhibit Hall
11:00 am – 11:10 am Award Presentations
11:15 am – 12:00 pm SGS5: Evidence Generation to Inform Medical Decisions
Moderator: Mack Harrell, MD
Speaker: Robert Califf, MD


Room: Ballroom D
CME Code: 1948
11:15 am – 12:00 pm SGS6: Late Breaking Oral Presentations (Non-CME)
Moderators: Lance Sloan, MD; Harmeet Singh Narula, MD REDICTABILITY OF DIABETES MELLITUS TYPE 2 REMISSION AND CHANGES IN METABOLIC PROFILE AFTER BARIATRIC SURGERY USING DIAREM SCORING SYSTEM
Thiyagarajan Thangavelu , MD

SERUM AUTOANTIBODIES DIRECTED TO THE GONADOTROPIN RELEASING HORMONE RECEPTOR ECL2 ARE DIAGNOSTIC OF PCOS
Myriam Elkosseifi, MD

AUTOMATED FREQUENT INSULIN DOSAGE TITRATIONS TO OVERCOME INSULINTHERAPY INEFFECTIVENESS
Israel Hodish, MD

Room: 17B
CME Code: 2472
12:00 pm – 2:15 pm Exhibit Hall Open
12:15 pm – 2:00 pm AACE Annual Business Meeting Luncheon
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  S11: Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


Room: 18AB
CME Code: 3774
  S21: Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


Room: 19
CME Code: 9808
  S31: Skin & Endocrine Disorders: Beyond the Usual
Moderator: Catalina Poiana, MD
Speaker: Michelle Tarbox, MD


Room: 17B
CME Code: 5603
  S41: Molecular Markers in Thyroid Nodule Evaluation
Moderator: Enrico Papini, MD
Speaker: Yuri Nikiforov, MD


Room: 18CD
CME Code: 1440
  S51: Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


Room: 16A
CME Code: 4728
  S61: Managing Transgender Youth
Moderator: Vin Tangpricha, MD
Speaker: Steve Rosenthal, MD


Room: 16B
CME Code: 7144
  S71: SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD;
Matthew Weir, MD


Room: 17A
CME Code: 1058
3:15 pm – 3:30 pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  S12: CGM in Pregnancy and Unique Populations
Moderator: Sandra Weber, MD
Speaker:Elizabeth Buschur, MD


Room: 16A
CME Code: 1349
  S22: Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker:Brian Casey,MD


Room: 17A
CME Code: 1884
  S32: Clinical Cases of Endocrine Hypertension
Moderator: M. Kathleen Figaro, MD
Speaker: Richard Auchus, MD


Room: 16B
CME Code: 1737
  S42: Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


Room: 18AB
CME Code: 7928
  S52: Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


Room: 1827
CME Code: 19
  S62: Skin & Endocrine Disorders: Beyond the Usual
Moderator: Jimmy Aragon, MD
Speaker: Michelle Tarbox, MD


Room: 17B
CME Code: 1827
  S72: Molecular Markers in Thyroid Nodule Evaluation
Moderator: Jonathan Leffert, MD
Speaker: Yuri Nikiforov, MD


Room: 18CD
CME Code: 3921
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  S13: Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


Room: 17B
CME Code: 4634
  S23: Managing Transgender Youth
Moderator: Ximena Lopez, MD
Speaker: Steve Rosenthal, MD


Room: 18AB
CME Code: 8908
  S33: SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD;
Matthew Weir, MD


Room: 18CD
CME Code: 8893
  S43: CGM in Pregnancy and Unique Populations
Moderator: Etie Moghissi, MD
Speaker:Elizabeth Buschur, MD


Room: 16A
CME Code: 2765
  S53: Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker: Brian Casey, MD


Room: 17A
CME Code: 9264
  S63: Clinical Cases of Endocrine Hypertension
Moderator: M. Kathleen Figaro, MD
Speaker: Richard Auchus, MD


Room: 16B
CME Code: 6562
  S73: Learning from Legends
Moderator: Elliot Sternthal, MD
Speakers:Lewis Braverman, MD


Room: 19
CME Code: 2801
6:30 pm ACE Convocation
7:30 pm President’s Gala

SUNDAY, MAY 7

7:00 am -11:00 am Attendee Registration
>7:30 am -12:00 pm CME Station Hours
8:00 am – 8:15 am General Session Announcements
8:15 am – 8:45 am SGS7: Multidisciplinary Approach to Endocrine Disease: MEN 2A
Moderator: Naifa L. Busaidy, MD
Panel: Naifa L. Busaidy, MD; David Terris, MD; Swati Mehrotra, MD


Room: Ballroom D
CME Code: 9041
8:45 am – 9:30 am SGS8: Multidisciplinary Approach to Endocrine Disease: Hypoparathyroidism
Moderator: Naifa L. Busaidy, MD
Panel: Naifa L. Busaidy, MD; David Terris, MD; Swati Mehrotra, MD


Room: Ballroom D
CME Code: 9939
9:30 am- 9:45 am Coffee Break
  President’s Announcements
9:45 am – 11:00 am SGS9: Multidisciplinary Approach to Endocrine Disease: Thyroid Cancer - Alpha to Omega
Co-Moderators: Peter Singer, MD; Greg Randolph, MD
Panel: Steve Sherman, MD; Yuri Nikiforov, MD


Room: Ballroom D
CME Code: 5632

Congress Program Agenda with
Educational Objectives

WEDNESDAY, MAY 3

8:00 am – 12:00 pm PRE CONGRESS SESSION I
*Additional Registration Fees May Apply.
  W11:Advanced Diabetes Technology Concepts
Chair: George Grunberger, MD
  • Insulin Pumps: Current Landscape
    Bruce W. Bode, MD
  • CGM: Moving Beyond SMBG
    George Grunberger, MD
  • Applications of Technology to Your Patients
    Irl B. Hirsch, MD
  • Moving Toward Artificial Pancreas (Non-CME)
    Moshe Phillip, MD
EDUCATIONAL OBJECTIVES:
  • Discuss the benefits and risks of insulin pump therapy along with the indications
  • Review the current insulin pumps FDA approved
  • Discuss initiation and follow up of insulin pumps
EDUCATIONAL OBJECTIVES:
  • Understand available insulin pumps and CGM devices on the market
  • Appreciate progress towards bionic pancreas
  • Be able to decide on optimizing insulin therapy using CGM and insulin pump download data
EDUCATIONAL OBJECTIVES:
  • Describe state-of-the-art technology needs for an endocrinologist's office in 2017
  • Review basics of download interpretations for currently available pumps/sensors
  • Review the technology on the horizon for diabetes management
EDUCATIONAL OBJECTIVES:
  • Describe the state of the art of automatic insulin delivery for patients with Diabetes
  • Discuss the different options for closing the loop
  • Visualize the future of digital clinic
  W21: Hot Topics in Bone Disease in 2017: Building Better Bones
Chairs: Rachel Pessah-Pollack, MD; Daniel Hurley, MD
  • Nutritional Impact on Bone Health
    Neil Binkley, MD
  • Brittle Bones in Diabetes: New Insights into Sweeter Bones
    Nelson Watts, MD
  • Creating New Bone: Use of Anabolic Agents
    Michael McClung, MD
  • Hot Topics: Breaking News in Osteoporosis
    Rachel Pessah-Pollack, MD; Daniel Hurley, MD
EDUCATIONAL OBJECTIVES:
  • Understand the controversy surrounding calcium supplementation and be able to make common sense-based recommendations regarding calcium intake
  • Appreciate the controversy surrounding definitions of vitamin D insufficiency and understand its potential impact on bone and muscle
  • Recognize the importance of protein intake for older adults to minimize sarcopenia
EDUCATIONAL OBJECTIVES:
  • Become familiar with the relationship of diabetes to fracture risk
  • Understand how to assess fracture risk in patients with diabetes
  • Describe mechanisms of increased fracture risk
EDUCATIONAL OBJECTIVES:
  • Define the actions of anti-remodeling and anabolic agents
  • Understand the differences in mechanisms of action of the types of anabolic therapy
  • Position the use of anabolic agents appropriately
EDUCATIONAL OBJECTIVES:
  • Discuss the use of antiresorptive agents in breast cancer patients at high risk for fracture, particularly those receiving aromatase inhibitor therapy
  • Assess the indication for denosumab as an adjuvant agent in breast cancer
  • Discuss the use of anabolic (teriparatide) therapy in orthopedic spinal fusion surgery.
  • Assess the efficacy of anabolic (teriparatide) therapy on fracture healing, to include atypical femoral fractures.
  W31: Providing Reproductive Endocrine Care in the Office
Chairs: Charles Faiman, MD; Rhoda Cobin, MD
  • Avoiding/Managing Androgen Abuse
    Sandeep Dhindsa, MD
  • What’s New with PCOS
    Jennifer Glueck, MD
  • Initial Workup of Infertile Couple
    Neil Goodman, MD; Kelly Chiles, MD
  • Choosing HRT in the Millenials
    Bruce Carr, MD
EDUCATIONAL OBJECTIVES:
  • Identify appropriate candidates for testosterone replacement therapy
  • Monitor testosterone replacement therapy
  • Acknowledge side-effects of testosterone therapy
EDUCATIONAL OBJECTIVES:
  • Describe new updates on the pathophysiology and diagnosis of PCOS, including Gene-Wide Association Study in PCOS, role of anti-mullerian hormone and issues in diagnosis of PCOS in adolescence
  • Present emerging treatment options for PCOS focusing on metabolic complications and weight management
  • Update on current evidence regarding long term health issues in women with PCOS including cardiovascular and postmenopausal risks
EDUCATIONAL OBJECTIVES:
  • Define infertility
  • Understand the evaluation and treatment of female infertility Manage ovulation induction
  • Summarize necessary components of history and physical
  • Formulate a differential diagnosis for etiology of infertility
  • Recommend appropriate lab and genetic test
EDUCATIONAL OBJECTIVES:
  • At the end of the presentation the attendee will understand the indications for treatment
  • At the end of the presentation the attendee will list the benefits of HRT
  • At the end of the presentaion the attendee will list the risks of HRT
  W41: Leading Edge of Practical Thyroidology
Chair: Mark Lupo, MD
  • It’s Not Your Thyroid
    Michael McDermott, MD

  • AACE Approach to Nodules
    Hossein Gharib, MD

  • Guide for Thyroid Cancer
    Brian Kim, MD
  • ATA Approach to Hyperthyroidism
    Doug Ross, MD
  • Practical Solutions for Practical Problems
    Mark Lupo, MD
EDUCATIONAL OBJECTIVES:
  • Discuss non-specific symptoms that may occur in thyroid disease and non-thyroid diseases
  • Review what we know and don't know about thyroid physiology and testing
  • Develop a practical approach to the management of patients who attribute their symptoms to their thyroid disease when this may or may not be the case
EDUCATIONAL OBJECTIVES:
  • To review and discuss highlights of 2016 AACE Thyroid Nodule Guidelines
  • To compare recommendations with 2015 ATA Thyroid Nodule/Cancer Guidelines
  • To discuss results of 2016 Practice Survey vis-à-vis guideline recommendations
EDUCATIONAL OBJECTIVES:
  • Recognize the major changes in thyroid cancer guidance from ATA 2015
  • Understand how to implement the new I-131 recommendations
  • Understand controversies in molecular genetic testing
EDUCATIONAL OBJECTIVES:
  • understand the use of antithyroid drugs in hyperthyroidism
  • understand the use of radioiodine in hyperthyroidism
  • understand the use of surgery in hyperthyroidism
EDUCATIONAL OBJECTIVES:
  • Understand the various codes used to bill thyroid ultrasound and FNA biopsy as well as the appropriate use of modifiers
  • Highlight the importance of ECNU certification and AIUM accreditation for both quality assurance and reimbursement
  • Increase the awareness of MACRA/MIPS as it pertains to thyroid practice
1:00 pm – 5:00 pm PRE CONGRESS SESSION II
*Additional Registration Fees May Apply.
  W12: Advanced Diabetes Technology Skills Practice
  • How to Set Up a Diabetes Technology Practice in the Real World
    Timothy Bailey, MD
  • Hands on Technology Demonstrations
  • Practical Case Solving Session
    George Grunberger, MD; Dace Trence, MD; Timothy Bailey, MD
EDUCATIONAL OBJECTIVES:
  • Use technology to gather important diabetes information from patient devices
  • Interpret software generated reports to assist in patient care
  • Choose appropriate diabetes software for use in-office
EDUCATIONAL OBJECTIVES:
  • Better define specific approaches to managment of diabetes in various patient presentations
  • Understand how to approach evaluation of why current patient managment approach is not optimally successful
  • Recognize limitations of current technology
  W22: The Practice of Obesity Medicine in 2017
Chair: Ken Fujioka, MD; W. Timothy Garvey, MD
  • Putting the AACE Obesity Guidelines into Practice
    W. Timothy Garvey, MD
  • Can Exercise Make Me Gain Weight?: Evidence Based Prescription
    Tim Church, MD
  • Safe Use of the New Weight Loss Medications
    Karl Nadolsky, DO
  • The Latest and Greatest on Weight Loss Diets and Bariatric Surgery
    Ken Fujioka, MD

EDUCATIONAL OBJECTIVES
  • Understand the conceptual basis of obesity as a chronic disease with complications and a natural history that conforms to primary, secondary, and tertiary phases of prevention & treatment
  • Have a working knowledge of the anthropometric and clinical components of the diagnosis of obesity
  • Develop a rational approach to treatment decisions and identify goals of therapy based on disease staging (e.g., when to use weight loss medications?)
  • Appreciate the practical application of the AACE obesity guidelines based on examples of patients with NAFLD/NASH and Polycystic Ovary Disease
EDUCATIONAL OBJECTIVES:
  • Provide an aerobic exercise prescription
  • Provide a resistance training prescription
  • Better understand the relationship between exercise and over eating
EDUCATIONAL OBJECTIVES:
  • Recognize basic indications, dosing, and monitoring of obesity medications
  • Review efficacy of obesity medications from phase 3 trials
  • Discuss nuances for personalized therapy
EDUCATIONAL OBJECTIVES:
  • Be able to identify and treat typical endocrine problems that are common after bariatric surgery for morbid obesity
  • Identify the benefits and risks of newer diets
  • Be able to understand the science behind the genetically personalized diets
  W:32 Endocrinologist - Surgeon: Critical Collaboration with Case-Based Conversations
Chairs: Mira Milas, MD; Jeffrey Garber, MD

  • Thyroid and Parathyroid Surgery
    Mira Milas, MD
  • Thyroid and Parathyroid Perioperative Endocrinology
    Jeffrey Garber,MD
  • Pituitary and Adrenal Perioperative Endocrinology
    Maria Fleseriu, MD
  • Pituitary Surgery
    Edward Laws, Jr., MD
  • Adrenal Surgery
    Dan Ruan, MD

EDUCATIONAL OBJECTIVES:
  • To review algorithms for inpatient and outpatient post thyroidectomy and parathyroidectomy calcium management
  • To highlight hospital-based challenges in patients with goiters Managing peri-operative thyroid dysfunction
EDUCATIONAL OBJECTIVES:
  • How the endocrine surgeon and endocrinologist co-manage perioperative hypothyroidism
  • How the endocrine surgeon and endocrinologist co-manage perioperative hyperthyroidism in the patient undergoing thyroidectomy for hyperthyroidism
  • How the endocrine surgeon and endocrinologist co-manage calcium perioperatively in the patient undergoing parathyroidectomy
EDUCATIONAL OBJECTIVES:
  • Recognize the morbidity associated with hypopituitarism before pituitary surgery
  • Review therapeutic options for treatment of hormonal dysfunction in the immediate period after pituitary surgery
  • Review algorithms for follow-up in patients after pituitary and adrenal surgery
EDUCATIONAL OBJECTIVES:
  • Describe the various surgical approaches to the pituitary region
  • Understand the indications for surgery in various types of pituitary lesions
  • Consider outcomes and adjuncts to pituitary surgery - medical and radiation therapy
EDUCATIONAL OBJECTIVES:
  • Complete the necessary workup prior to parathyroidectomy and adrenalectomy
  • Inform their patients regarding the risks and benefits of parathyroidectomy and adrenalectomy
  • Apply appropriate postoperative screening and treatment
1:00 pm – 5:30 pm W42: AACE Board Review & MOC Course
Moderator: Pauline Camacho, MD
Speaker: Pauline Camacho, MD; Elise Brett, MD; S. Sethu K. Reddy, MD

EDUCATIONAL OBJECTIVES:
  • To review cases and questions on endocrine topics including diabetes, bone, thyroid, adrenal, lipids, nutrition, pediatric, pituitary reproductive and hypoglycemia.
56:00 pm – 6:00 pm Dinner
5:30 pm – 7:45 pm Satellite Symposia

WSS1: Burning Questions about New and Emerging Injectable Therapies for Type 2 Diabetes: A Hot Topics Presentation

Supported by an educational grant from Novo Nordisk
 

WSS2: A Town Hall Series on Improving Access to PCSK9 Inhibitors: Issues and Recommendations Clinicians (Non-CME)

Supported by Amgen, Inc., Sanofi and Regeneron

THURSDAY, MAY 4

5:15 am – 5:45 am Breakfast
5:15 am – 7:30 am Satellite Symposia

TSS1: Continuous Glucose Monitoring as the Standard of Care: Clinical Outcomes, Improved Access and Non-Adjunctive Use

Supported by an educational grant from Dexcom
 

TSS2: Current Landscape in Medullary Thyroid Cancer: Update for Clinicians

Supported by an educational grant from Genzyme, A Sanofi Company
6:30 am - 6:00 pm Attendee Registration
7:00 am - 6:00 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am – 8:30 am General Session Announcements
8:30 am – 9:15 am TGS1: "But Why Bone?"
Moderator: Pauline Camacho, MD
Speaker: Gerard Karsenty, MD

EDUCATIONAL OBJECTIVES:
  • To explain the reasoning that led to the suspicion that bone is an endocrine organ regulating energy metabolism and reproduction
  • To describe the various functions of the bone-derived hormone osteocalcin
  • To infer from the known functions of osteocalcin an overall purpose for the endocrine functions of bone
9:15 am – 10:00 am TGS2: Precision Medicine for Diabetes: Where Are We?
Moderator: Vivian Fonseca, MD
Speaker: Judith Fradkin, MD


EDUCATIONAL OBJECTIVES:
  • Be able to describe the cohort and the data to be collected in the “All of Us” study, the NIH component of the Precision Medicine initiative
  • Be able to identify the drug classes being compared in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
  • Be able to discuss the comparative effectiveness of lifestyle and metformin in delaying type 2 diabetes in the Diabetes Prevention Program overall and in specific subpopulations
10:00 am – 11:00 am Young Investigator Poster Session in Exhibit Hall
10:15 am – 11:00 am Product Theaters in the Exhibit Hall (2)
11:05 am - 11:15 am Award Presentations
11:15 am – 12:00 pm TGS3: Diabetes Management: Applications of High Tech Innovations
Moderator: George Grunberger, MD
Speaker: William Tamborlane, MD

EDUCATIONAL OBJECTIVES:
  • Describe advances in Continuous Glucose Monitoring (CGM) that are driving the increased use of CGM in patients with T1D
  • Relate the recent history of artificial pancreas development
  • Evaluate the pros and cons of hybrid closed-loop versus full closed-loop insulin delivery
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm Young Investigator ePoster Oral Presentations
12:30 pm – 2:15 pm Women's Luncheon: Female Physicians and the Future of Endocrinology (Non-CME)
Moderator: Etie S. Moghissi, MD
Speaker: Ann Danoff, MD
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15pm – 2:00 pm Product Theaters (2) in the Exhibit Hall
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  T11: Different Approach to Obesity in T1D vs. T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard Pratley, MD


EDUCATIONAL OBJECTIVES
  • Describe the components of energy expenditure and how dysregulation of energy balance affects the development of obesity
  • Explain how type 1 and type 2 diabetes affect energy expenditure and energy balance 3)
  • Discuss approaches and the evidence base for treating obesity in T1D and T2DM
  T21: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


EDUCATIONAL OBJECTIVES:
  • Discuss the state of the art of center of ecellence in T1DM clinics
  • Discuss the future of digital clinics
  • Discuss the pro and cons of automated systems in the care of T1DM
  T31: Evolving to Precision Thyroid Cancer Care
Moderator: Steven De Jong, MD
Speaker: Matt Ringel, MD


EDUCATIONAL OBJECTIVES:
  • Understand recommendations regarding use of I-131 therapy
  • Define patients appropriate for consideration of kinase therapy
  • Understand role of genomic testing in thyroid cancer management
  T41: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD

Special Guest: John Kanis, MD

EDUCATIONAL OBJECTIVES:
  • Identify clinical risk factors that affect the performance of FRAX
  • Identify how to accommodate the effect of these risk factors in FRAX
  • Explain how to use FRAX in clinical decision-making in patients with these risk factors
  T51: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


EDUCATIONAL OBJECTIVES:
  • Know when it is appropriate to stop growth hormone therapy in children.
  • Learn how to test for GH deficiency
  • Learn how to assess effectiveness of GH therapy in young adults
  T61: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


EDUCATIONAL OBJECTIVES:
  • Describe symptoms and signs commonly presented by the pseudo-endocrine patient
  • Review diagnostic evaluations appropriate for the pseudo-endocrine patient
  • Discuss management strategies for the pseudo-endocrine patient
  T71: Personalized Diabetes Management: Cultural Considerations
Co-moderators: Jeffrey Mechanick, MD; Martin Grajower, MD
Speaker: Osama Hamdy, MD; Shashank Joshi, MD


EDUCATIONAL OBJECTIVES:
  • Understand the physiologic changes during Ramadan Fasting
  • Craft a dietary plan that has less impact of blood glucose levels
  • Mange diabetes properly with medications during Ramadan Fasting
EDUCATIONAL OBJECTIVES:
  • Using trans cultural algorithms to integrate with standards of care especially in lifestyle interventions of medical nutrition therapy, physical activity , weight loss and behavioral modification therapy.
  • Using trans cultural algorithms to integrate with standards of care especially in lifestyle interventions of medical nutrition therapy, physical activity , weight loss and behavioral modification therapy
  • Patient-centered care despite of conflicting standardized algorithmic management is necessary to translate the treatment into a compliant personalized therapy. Personalized treatment approach in which drugs are tested in a trial-and-error manner to achieve therapeutic targets
3:15pm-3:30pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  T12: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul Jellinger, MD


EDUCATIONAL OBJECTIVES:
  • Be able to identify a new risk category "Extreme Risk"
  • Understand the four different CV risk Calculators
  T22: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


EDUCATIONAL OBJECTIVES:
  • To describe simple clinical tests in the identification of the “at risk” diabetic foot that will include both the Ipswich Touch Test and the “Vibratip”
  • To understand the importance of skin temperature monitoring in the identification of a “pre-ulcerative” high risk foot and in the diagnosis of acute Charcot neuroarthropathy
  • To contrast the use of different scanning techniques including the plain x-ray, MRI and CT in the diagnosis of osteomyelitis and Charcot neuroarthropathy
  T32: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


EDUCATIONAL OBJECTIVES:
  • Identify the types of endocrine dysfunction which can be induced by immunotherapy
  • Review the management of immunotherapy induced endocrine dysfunction
  • Review the mechanisms and treatments of targeted therapy associated metabolic dysfunction
  T42: Different Approach to Obesity in T1D vs T2DM
Moderator: Scott Isaacs, MD
Speaker: Richard Pratley, MD


EDUCATIONAL OBJECTIVES:
  • Describe the components of energy expenditure and how dysregulation of energy balance affects the development of obesity
  • Explain how type 1 and type 2 diabetes affect energy expenditure and energy balance 3)
  • Discuss approaches and the evidence base for treating obesity in T1D and T2DM
  T52: Evolving to Precision Thyroid Cancer Care
Moderator: Steven De Jong, MD
Speaker:Matt Ringel, MD


EDUCATIONAL OBJECTIVES:
  • Understand recommendations regarding use of I-131 therapy
  • Define patients appropriate for consideration of kinase therapy
  • Understand role of genomic testing in thyroid cancer management
  T62: FRAX in Diabetes and Underserved Populations
Moderator: Anne Leddy, MD
Speaker: William Leslie, MD

Special Guest: John Kanis, MD

EDUCATIONAL OBJECTIVES:
  • Identify clinical risk factors that affect the performance of FRAX
  • Identify how to accommodate the effect of these risk factors in FRAX
  • Explain how to use FRAX in clinical decision-making in patients with these risk factors
  T72: Transition for the Growth Hormone Treated Patient from the Pediatric to Adult Clinic
Moderator: Jay Cohen, MD
Speaker: Andrew Hoffman, MD


EDUCATIONAL OBJECTIVES:
  • Know when it is appropriate to stop growth hormone therapy in children.
  • Learn how to test for GH deficiency
  • Learn how to assess effectiveness of GH therapy in young adults
4:30 pm – 4:45 pm Break
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  T13: Approach to Pseudo Endocrine Patients
Moderator: William Zigrang, MD
Speaker: Michael Mcdermott, MD


EDUCATIONAL OBJECTIVES:
  • Describe symptoms and signs commonly presented by the pseudo-endocrine patient
  • Review diagnostic evaluations appropriate for the pseudo-endocrine patient
  • Discuss management strategies for the pseudo-endocrine patient
  T23: Decision Support System for the Treatment of Diabetes (Non-CME)
Moderator: Kathleen Wyne, MD
Speaker: Moshe Phillip, MD


EDUCATIONAL OBJECTIVES:
  • Discuss the state of the art of center of ecellence in T1DM clinics
  • Discuss the future of digital clinics
  • Discuss the pro and cons of automated systems in the care of T1DM
  T33: Personalized Diabetes Management: Cultural Considerations
Co-moderators: Jeffrey Mechanick, MD; Martin Grajower, MD
Speaker: Osama Hamdy, MD; Shashank Joshi, MD


EDUCATIONAL OBJECTIVES:
  • Understand the physiologic changes during Ramadan Fasting
  • Craft a dietary plan that has less impact of blood glucose levels
  • Mange diabetes properly with medications during Ramadan Fasting
EDUCATIONAL OBJECTIVES:
  • Using trans cultural algorithms to integrate with standards of care especially in lifestyle interventions of medical nutrition therapy, physical activity , weight loss and behavioral modification therapy.
  • Using trans cultural algorithms to integrate with standards of care especially in lifestyle interventions of medical nutrition therapy, physical activity , weight loss and behavioral modification therapy
  • Patient-centered care despite of conflicting standardized algorithmic management is necessary to translate the treatment into a compliant personalized therapy. Personalized treatment approach in which drugs are tested in a trial-and-error manner to achieve therapeutic targets
  T43: Endocrine Care of Oncology Patients
Moderator: Janet McGill, MD
Speaker: Conor Best, MD


EDUCATIONAL OBJECTIVES:
  • Identify the types of endocrine dysfunction which can be induced by immunotherapy.
  • Review the management of immunotherapy induced endocrine dysfunction.
  • Review the mechanisms and treatments of targeted therapy associated metabolic dysfunction.
  T53: Diabetic Foot: Diagnostic Innovations for the Endocrinologist
Moderator: Cheryl Rosenfeld, DO
Speaker: Andrew Boulton, MD


EDUCATIONAL OBJECTIVES:
  • To describe simple clinical tests in the identification of the “at risk” diabetic foot that will include both the Ipswich Touch Test and the “Vibratip”
  • To understand the importance of skin temperature monitoring in the identification of a “pre-ulcerative” high risk foot and in the diagnosis of acute Charcot neuroarthropathy
  • To contrast the use of different scanning techniques including the plain x-ray, MRI and CT in the diagnosis of osteomyelitis and Charcot neuroarthropathy
  T63: Interpreting Lipid Guidelines: How Low Should You Go?
Moderator: Chris Guerin, MD
Speaker: Yehuda Handelsman, MD; Paul Jellinger, MD


EDUCATIONAL OBJECTIVES:
  • Be able to identify a new risk category "Extreme Risk"
  • Understand the four different CV risk Calculators
  T73: Learning From Legends
Moderator: Sethu Reddy, MD
Speaker: Edward Horton, MD


EDUCATIONAL OBJECTIVES:
  • Understand the evolutionof our knowledge about obesity and effects of physical exercise over the past 50 years
  • Understand the metabolic effects of exercise and weight reduction
  • Understand the effects of overfeeding and weight gain in normal subjects
6:00 pm – 7:00 pm Domestic & International Chapter Receptions
7:15 pm – 7:45 pm Dinner
7:15 pm – 9:30 pm Satellite Symposia

TSS3: Using Insulin When, Where and How It's Needed: Type 2 Diabetes Treatment in the Modern Age
Supported by an educational grant from Sanofi US

TSS4: UPDATES ABOUND! Latest and Greatest in Practical Application of Cardiovascular Outcomes for Diabetes Drugs
Supported by an educational grant from AstraZeneca

FRIDAY, MAY 5

5:15 am – 5:45 am Breakfast
5:15 am – 7:30 am Satellite Symposia

FSS1: Standardized Glucose Reporting - The New EKG for Diabetes?
Supported by an educational grant from Abbott
>7:30 am - 6:30 pm Attendee Registration
7:30 am - 6:00 pm CME Station Hours
10:30 am - 3:30 pm Exhibit Hall Hours
8:00 am - 8:15 am Award Presentations
8:20 am – 9:05 am Osteoporosis: History of FRAX
Moderator: Steven Petak, MD
Speaker: John Kanis, MD



EDUCATIONAL OBJECTIVES:
  • Illustrate care gaps in the management of osteoporosis
  • Provide information on fracture risk assessment using FRAX
  • Illustrate the benefits of fracture liaison services
9:15 am – 12:00 pm IN-DEPTH SYMPOSIA SESSION I
  Heart Failure: The Frequent, Forgotten and Fatal Complication of Type 2 Diabetes
Chair: David Bell, MD
  • Etiology and Prevalence of Diabetic Heart Failure
    David Bell, MD
  • Effects of Anti-Hyperglycemic Drug Therapy in Diabetic Heart Failure
    Richard Gilbert, MD
  • Role of Autonomic Neuropathy in Diabetic Heart Failure
    Aaron Vinik, MD
EDUCATIONAL OBJECTIVES:
  • Describe the prevalence of Type 2 Diabetes in hospitalized heart failure patients
  • Interpret the etiology of heart failure in the type 2 diabetic subject
  • Recognize the cause for the poor outcomes in type 2 diabetic subjects with heart failure
EDUCATIONAL OBJECTIVES:
  • Review the epidemiology of heart failure in diabetes
  • Explore the pathogenesis of heart failure in diabetes
  • Examine the detrimental and beneficial effects of anti-hyperglycemic agents
EDUCATIONAL OBJECTIVES:
  • Recognize the presentation of autonomic dysfunction
  • Understand the value of diagnosing and predicting cardiovascular outcome
  • Learn an algorithm for diabetes management that incorporates autonomic dysfunction
  The Transition Process: Key to Continued Best Endocrine Care
Chairs: Robert Rapaport, MD; Jay Cohen, MD
  • Type 2 diabetes
    Stuart Brink, MD
  • Metabolic Adult Consequences of Being Born Small
    Robert Rapaport, MD
  • Transgender
    Ximena Lopez, MD
  • Oncotherapy
    Charles Sklar, MD
EDUCATIONAL OBJECTIVES:
  • Identify target population re: younger patients with T2DM risk
  • Identify family and individual issues to address considering transition of care from family to young adult
  • Be familiar with psychosocial and medical treatment options to consider for adolescents and young adults with T2DM
EDUCATIONAL OBJECTIVES:
  • Understand definition of SGA and become familiar with growth of patients with SGA
  • Get to know the role of growth hormone in managing SGA
  • Become aware of the adult consequences of being born SGA
EDUCATIONAL OBJECTIVES:
  • Understand the psychological and sociomotional needs of transgender youth
  • Understand the differences between pediatric and adult transgender health care
  • Learn tools to facilitate transition of pediatric to adult care for transgender youth
EDUCATIONAL OBJECTIVES:
  • Recognize the cancer treatments associated with risk for late-occurring endocrine disorders
  • Estimate an individual survivors risk for specific endocrine disorders
  • Evaluate at risk survivors for potential late-occurring endocrine disorders
  Innovations in Evaluation and Management of Adrenal Diseases
Chair: Karel Pacak, MD
  • Evaluation of Adrenal Function in Critically Ill Patients
    Amir Hamrahian, MD
  • Pearls and Pitfalls in the Management of Cushing’s Syndrome
    Lynnette Nieman, MD
  • Current Evaluation and Management of Patients with Adrenocortical Carcinoma
    Gary Hammer, MD
EDUCATIONAL OBJECTIVES:
  • Review the regulation of hypothalamic-pituitary-adrenal axis in critically ill patients
  • Review the concept of relative adrenal insufficiency in critically ill patients
  • Discuss the algorithm for evaluation of adrenal function in critically ill patients
EDUCATIONAL OBJECTIVES:
  • Interpret the results of petrosal sinus sampling
  • Individualize the choice of screening tests for Cushing’s syndrome
  • Formulate a strategy to localize an ectopic ACTH-producing tumor
EDUCATIONAL OBJECTIVES:
  • To become familiar with the work-up of adrenal nodules
  • To understand general principles of the management of adrenocortical carcinoma
  • To understand the role of genetics in the pathobiology of adrenal cancer
  Integrating Guidelines, Experience and Clinical Judgement in the Management of Thyroid Cancer
Chair: Peter Singer, MD
Supported by the Hossain Gharib, MD Educational Fund
  • How Will the Latest Guidelines Affect the Endocrinologist’s Management of Thyroid Cancer?
    Bryan Haugen, MD
  • How Will the Guidelines Affect Surgical Management?
    Julie Ann Sosa, MD
  • Tackling the Problem of Thyroid Cancer Resistant to Conventional Therapy
    Mike Tuttle, MD
  • Putting It All Together with Challenging Cases
    Peter Singer, MD
EDUCATIONAL OBJECTIVES:
  • Describe major changes in the 2015 ATA Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer and how these should be applied in clinical practice
  • Implement the latest ultrasound risk stratification model in choosing which patients with thyroid nodules should undergo fine-needle aspiration biopsy and which patients can be monitored
  • Apply risk stratification and response to therapy as modifiers of recurrence risk to personalize long-term management and monitoring in patients with DTC
EDUCATIONAL OBJECTIVES:
  • To understand how the new ATA guidelines change perioperative (pre- and post-op) management
  • To understand how the new ATA guidelines change surgical strategies
  • To be familiar with the pivotal studies that have served as the underpinnings for these surgical management recommendations
EDUCATIONAL OBJECTIVES:
  • To review clinical characteristics of resistant thyroid cancer
  • To review expected clinical outcomes in resistant thyroid cancer
  • To review treatment options in resistant thyroid cancer
EDUCATIONAL OBJECTIVES:
  • Compare the 2015 ATA guidelines with the previously published guidelines
  • Understand the 2015 guidelines
  • Ensure that the 2015 guidelines are put in the proper clinical context
  Practical Issues for Nurse Practitioners/Physician Assistants in an Endocrine Practice
Chairs: W. Reid Litchfield, MD; Sondra O’ Callaghan, PA
  • Practical Osteoporosis Management
    Tom Blevins, MD
  • Ins & Outs of Intensive DM1 Management
    Israel Hartman, MD
  • The Spectrum of Autoimmune Endocrinopathies
    Hanford Yau, MD
  • Strategies to Integrate Non-Physicians into an Endocrine Practice
    Reid Litchfield, MD; Sondra O’Callaghan, PA-C
EDUCATIONAL OBJECTIVES:
  • Understand diagnosis of low bone mass and osteoporosis
  • Understand how to interpret bone density reports and FRAX scores
  • Discuss the pros and cons of treatment alternatives osteoporosis
EDUCATIONAL OBJECTIVES:
  • Describe the appropriate use of new Insulins
  • Review Pharmacology of New Insulins
  • Review appropriate combinations New Insulin
EDUCATIONAL OBJECTIVES:
  • Review the different types of autoimmune endocrinopathies
  • Evaluate autoimmune endocrinopathies clinically through biochemical testing
  • Manage common autoimmune endocrinopathies
EDUCATIONAL OBJECTIVES:
  • To compare various provider roles in the endocrine outpatient and inpatient setting
  • To examine patient satisfaction by provider type
  • To identify strategies to integrate nonphysician providers into endocrine practice
  • identify practice strategies the improve integration of non-physicians into the practice
  • identify strategies that the supervising endocrinologist can adopt to improve integration of the non-physician into their practice
  • identify strategies that the non-physician can implement to improve their integration into an endocrine practice
12:00 pm – 2:15 pm Exhibit Hall Break
12:00 pm – 1:00 pm Box Lunch with Exhibitors
12:00 pm – 12:45 pm ePoster Oral Presentations
12:30 pm – 2:15 pm Fellows-In-Training Luncheon
12:45 pm – 1:30 pm Product Theater in the Exhibit Hall
1:15 pm – 2:00 pm Product Theaters in the Exhibit Hall (2)
2:15 pm – 5:00 pm IN-DEPTH SYMPOSIA SESSION II
  The Diabetic Foot: Clear and Unpleasant Danger
Chairs: Andrew Boulton, MD; David Armstrong, MD
  • The Diabetic Foot
    Andrew Boulton, MD
  • What Can the Podiatric Surgeon Do for Me?
    William Grant, MD
  • The Toe and Flow Model for the High Risk Foot- Toward a National Model
    Christian Ochoa, MD
  • Keeping the Diabetic Foot in Remission
    David Armstrong, MD
EDUCATIONAL OBJECTIVES:
  • To understand that diabetic foot problems occur worldwide, should be easily preventable and constitute a major contribution to expenditure on diabetic complications.
  • To understand that whereas peripheral neuropathy and peripheral vascular disease are major contributory factors in the genesis of foot ulceration, screening for neuropathy is often neglected leading to many preventable foot problems.
  • To understand that a team approach to diabetic foot screening and care, including physicians, podiatrists, nurse educators and many other health care professionals has been shown to reduce the incidence of foot ulcerations and amputations worldwide.
EDUCATIONAL OBJECTIVES:
  • Understand the historic classifications of charcot diabetic foot
  • Understand the intersection of charcot disease process with resultant physical deformity
  • Have an eponym at their disposal to quickly evaluate a charcot foor and communicate their findings with other practitioners
EDUCATIONAL OBJECTIVES:
  • To identify patients with peripheral vascular disease and to obtain the appropriate non-invasive vascular studies
  • Describe the difference between claudication and critical limb ischemia
  • Understand the various treatments that are available for the lower limb revascularization
EDUCATIONAL OBJECTIVES:
  • Understand the modes of treatment of the diabetic foot
  • Identify benefits or the team approach
  • Identify novel modes of treatment
  State-of-the-Art Treatment of Obesity in Your Practice
Chairs: W. Timothy Garvey, MD; Michael Bush, MD
  • Hormones and Neurons: Appetite Regulation and Weight Control
    Michael Bush, MD
  • Culinary Medicine in the Treatment of Obesity
    Tim Harlan, MD
  • The Therapeutic Toolbox: Medications, Endoscopic Devices and Surgery
    Lee Kaplan, MD
  • Implementing the AACE Obesity Algorithm
    W. Timothy Garvey, MD
EDUCATIONAL OBJECTIVES:
  • State the mechanism behind the obesity of the OB mouse
  • State the role of the MC4 Receptor in controlling appetite
  • Contrast the effect of PYY and ghrelin on appetite
EDUCATIONAL OBJECTIVES:
  • Describe the health benefits of each fundamental Mediterranean diet component.
  • Defend the importance of a physician’s role in order to nurture healthy lifestyles and alleviate diet-related illness.
  • Justify the importance of relating to your audience in terms of food, not nutrients to make healthier food choices.
EDUCATIONAL OBJECTIVES:
  • Describe how the physiology of energy balance and body weight regulation can guide the care of patients with obesity
  • Approach the discussion and care of obesity with individual patients
  • Develop an appropriate pathway of clinical care for patients with obesity
EDUCATIONAL OBJECTIVES:
  • Gain a practical working knowledge of the evidence-based AACE obesity guidelines including screening, diagnosis, disease staging, treatment decisions, and the goals of therapy
  • Appreciate how disease staging in obesity can be used to augment benefit/risk and cost effectiveness of treatments: the case of prediabetes
  • Understand the rational application of the AACE obesity guidelines in clinical settings: (i) Obstructive Sleep Apnea, and (ii) Type 2 Diabetes
  Metabolic Bone Disease: What's New in 2017?
Chair: Pauline Camacho, MD
  • Diabetes and Bone
    Clifford Rosen, MD
  • Applying the AACE Postmenopausal Osteoporosis Guidelines
    Pauline Camacho, MD; Steven Petak, MD
  • Upcoming Agents for Osteoporosis
    Michael McClung, MD
  • Vitamin D and Diabetes: Evidence Based Clinical Recommendations
    Anastassios Pittas, MD
EDUCATIONAL OBJECTIVES:
  • To discuss the latest recommendations for the diagnosis and treatment of postmenopausal osteoporosis
  • To review the 2016 AACE Postmenopausal Osteoporosis Treatment Algorithm
  • To discuss controversies in the long term management of postmenopausal osteoporosis
  • Understand the cellular defects in bone from hyperglycemia
  • Define the clinical manifestations of diabetic osteopathy
  • Delineate the treatment options for diabetic bone disease
EDUCATIONAL OBJECTIVES:
  • Apply the AACE guidelines to prevention of osteoporosis
  • Review approach to those that can benefit the most from pharmacological therapy
  • Differentiate treatment options to individualize therapy approach
EDUCATIONAL OBJECTIVES:
  • Summarize the effectiveness and limitations of current treatments
  • Interpret the results of studies evaluating the skeletal effects of abaloparatide
  • Explain the treatment effects of inhibiting sclerostin activity
EDUCATIONAL OBJECTIVES:
  • To review the evidence behind the potential link between vitamin D and type 2 diabetes
  • To appreciate the potential pitfalls in interpreting the available evidence
  • To review current recommendations and review ongoing studies on vitamin D and diabetes
  The Aging Patient: Endocrinology for the Ages
Chair: Robert M. Palmer, MD
  • Diabetes in Older Adults
    Sue Kirkman, MD
  • Andropause and Aging
    Sandeep Dhindsa, MD
  • Endocrinology of Sarcopenia
    John Morley, MB, Bch.
  • Endocrinology of Aging: “Fountain of Youth” Real or Mythical?
    S. Sethu Reddy, MD
EDUCATIONAL OBJECTIVES:
  • Discuss the heterogeneity of older adults with diabetes.
  • Discuss the interaction of duration of diabetes, comorbidities, functional status, and vulnerability to hypoglycemia on the balance of potential benefits and harms of treatment of diabetes.
  • List several major research gaps in understanding how best to treat older patients with diabetes.
EDUCATIONAL OBJECTIVES:
  • Hypogonadism and the skeletal muscle
  • The effects of testosterone on anabolic functions
  • The possible role of testosterone supplementation in hypogonadism related to aging
EDUCATIONAL OBJECTIVES:
  • Recognize the importance of sarcopenia in diabetes
  • Know the role of testosterone in sarcopenia
  • Have a plan to treat sarcopenia
EDUCATIONAL OBJECTIVES:
  • Examine the evidence for a role of the endocrine system in the aging process
  • Explain the most popular anti-aging targets
  • Discuss with patients and peers of future status of endocrine-based anti-aging treatments
  Sustaining Your Endocrine Practice
Chair: Richard Haas, MD
  • The role of PAs/NPs in your Endocrine Practice
    Bill Law, Jr., MD
  • How the Trump Presidency will affect Health Care
    Jill Rathbun, MHSA
  • AACE and Quality Payment Program (QPP) - Where Are We Going?
    Howard Lando, MD; Felice Caldarella, MD
EDUCATIONAL OBJECTIVES:
  • Appreciate the benefit to society of increasing the availability of excellent endocrine and diabetes care
  • Understand the logistical and economic value of incorporating extenders into their practice
  • Create an effective transitional plan for incorporation of extenders into their practice
EDUCATIONAL OBJECTIVES:
  • Articulate the impact that the new Trump Administration is having on physician payments
  • Understand all the elements of the quality payment program and how they will participate
  • Make an operational plan to avoid negative payment adjustments from Medicare in 2019
EDUCATIONAL OBJECTIVES:
  • What is the Quality Payment Program?
  • What is the Merit-based Incentive Payment Systems (MIPS)
  • What do you need to do in your practice?
  • What is an APM?
  • Why is an APM important to you?
  • What is in the DM APM?
5:00 pm - 6:00 pm Open Discussion of Alternate Business Models for Endocrine Practices
  Insulin Resistance in Latinos : A Nationwide Epidemic
Chairs: Myriam Allende- Vigo, MD; Valentin Sanchez, MD
In conjunction with SMNE
  • Results of the Type 1 Diabetes Registry in Mexico: RENACED Diabetes Tipo 1
    Raquel Faradji, MD
  • Insulin Resistance and its Effects of New Therapies in Type 2 Diabetes Hispano/Latino Patients
    Guillermo Gonzalez Galvez, MD
  • Diabetes Mellitus Trends in Hispanic/Latino Population
    Larissa Aviles-Santa, MD
  • Subclinical Cushing’s
    Alejandro Ayala, MD
  • Ectopic ACTH Syndrome: A Tertiary Care Center Experience
    Claudia Ramirez Rentería, MD
EDUCATIONAL OBJECTIVES:
  • Learn how to define insulin resistance in Type 1 diabetes
  • Learn how to recognize insulin resistance in patients living with Type 1 diabetes, and how it is different in the Latino population
  • Learn possible interventions to reduce insulin resistance in Type 1 diabetes
EDUCATIONAL OBJECTIVES:
  • Recognize the clinical impact of type 2 diabetes in Mexico
  • The metabolic response of the new therapies for type 2 diabetes in Latino populations
  • The impact of some therapies to cardiovascular events in Latino populations
EDUCATIONAL OBJECTIVES:
  • Understand differences in prevalence of diabetes mellitus among Hispanic/Latino populations
  • Identify factors that mediate risk for diabetes mellitus among Hispanic/Latino populations
  • Discuss potential areas of research on mechanisms of disease and prevention
EDUCATIONAL OBJECTIVES:
  • Identify subtle form of Cushing's syndrome
  • Review the influence of spectrum bias in the diagnostic performance of screening tests used to identify Cushing's syndrome
  • Propose an approach to the treatment/long term follow up of patients with suspected mild Cushing syndrome
EDUCATIONAL OBJECTIVES:
  • Understand the importance of early diagnosis and treatment of Ectopic ACTH-producing tumors
  • Make proper use of information on diagnostic and therapeutic tools available today
  • Realize the need for a long term and comprehensive follow up of functioning neuroendcrine tumor
5:00 pm – 6:30 pm Poster-Viewing Wine & Cheese Reception in Exhibit Hall
5:00 pm – 6:15 pm Poster Session in Exhibit Hall
6:15 pm – 7:00 pm Product Theaters
7:00 pm – 7:30 pm Dinner
7:00 pm – 9:15 pm Satellite Symposia

FSS3: Hypoparathyroidism: Evolving Presentation, Incorporating Guidelines and Optimizing Treatment
Supported by an educational grant from Shire
  FSS4: Treatment Advances for Challenging Patients with Type 2 Diabetes: The Role of Emerging Insulin Combinations
Supported by an educational grant from Sanofi

SATURDAY, MAY 6

7:30 am -5:00 pm Attendee Registration
7:30 am -6:00 pm CME Station Hours
9:45 am - 2:15 pm Exhibit Hall Hours
8:00 am – 8:10 am Poster Award Presentations
8:10 am – 8:15 am Award Presentation
8:15 am – 9:00 am Evolution and Revolution of Radioiodine Refractory Thyroid Cancer
Moderator: Felice Caldarella, MD
Speaker: Steve Sherman, MD


EDUCATIONAL OBJECTIVES:
  • To define the various characteristics of radioiodine refractory thyroid cancer in clinical practice
  • To select among approved and novel systemic treatment options for patients with radioiodine refractory thyroid cancer
  • To identify patients who might participate in clinical trials of investigational therapies
9:00 am - 9:15 am Award Presentations
9:15 am – 10:00 am Advances in Pituitary
Moderator: Susan Samson, MD
Speaker: Anne Klibanski, MD


EDUCATIONAL OBJECTIVES:
  • Understand the diagnostic evaluation for prolactinomas
  • Describe diagnostic criteria for acromegaly and Cushings disease
  • Describe therapeutic options for secretory pituitary tumors
9:15 am – 10:00 am SGS3: Select Abstract Oral Presentations I
Moderator: David C. Lieb, MD

AN ASSESSMENT OF EASE OF READABILITY OF ONLINE PATIENT EDUCATION MATERIAL ON THYROID CANCER TREATMENT: NOT SO READABLE AFTERALL
Rashika Bansal, MD

SIX YEAR CLINICAL AND IMAGING FOLLOW UP OF AN OFFICE BASED GENE EXPRESSION CLASSIFIER USED TO MANAGE THYROID NODULES
Brian Michael, MD

22 MONTH REVIEW OF IMMUNE CHECKPOINT INHBITOR ASSOCIATED ENDOCRINE DISORDERS AT A SOUTHERN CALIFORNIA TEACHING HOSPITAL
Lauren Clarine, DO

EDUCATIONAL OBJECTIVES:
  • To assess the readability of the treatment options of thyroid cancer related patient education materials
  • To determine whether the patient education materials on thyroid cancer treatment options are on par with recommendations
  • To identify the need to revise patient education materials patient education materials on thyroid cancer treatment options
EDUCATIONAL OBJECTIVES:
  • Understand current use of gene expression classifier technology in the management of thyroid nodular disease
  • Understand practical outcomes and potential benefits of using this technology
  • Understand potential benefits of reduced patient exposure to thyroid surgery
EDUCATIONAL OBJECTIVES:
  • Recognize that endocrine immune related adverse events occur with the use of a new type of cancer treatment, immune checkpoint inhibitor therapy
  • Identify the prevalence and clinical presentation of specific endocrine immune related adverse events which occur with use of cytotoxic T lymphocyte antigen 4 (CTLA4) and programmed death 1 (PD1) immune checkpoint inhibitors
  • Formulate screening protocols for the development of endocrine disorders as well as guidelines for management of endocrine
9:15 am – 10:00 am Select Abstract Oral Presentations II
Moderator: Matthew Levine, MD

EFFECTS OF CANAGLIFLOZIN VERSUS GLIMEPIRIDE ON ADIPOKINES, INFLAMMATORY BIOMARKERS, AND CHEMOKINES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
W. Timothy Garvey, MD

CLINICAL PREDICTORS OF PROGRESSION TO INSULIN USE AMONG CHINESE PATIENTS WITH TYPE 2 DIABETES- THE HONG KONG DIABETES REGISTRY
Ronald Ma, MB, BCh.

VALUE OF CHRONIC DISEASE REGISTRY IN EVALUATING PREDICTORS FOR DIABETES-RELATED CLINICAL INERTIA
Wael Eid, MD

EDUCATIONAL OBJECTIVES:
EDUCATIONAL OBJECTIVES:
  • Highrisk the risk of disease progression among patients with Type 2 diabetes
  • Identify the factors associated with progression
  • Discuss the role of different factors in the pathogenesis of diabetes progression
EDUCATIONAL OBJECTIVES:
  • Identify the potential of a chronic disease registry in evaluating the state of a disease within the healthcare system
  • Identify clinical inertia in relations to diabetes mellitus and its predictors
  • Identify the value of chronic disease registry in planning patient-centered care for high-risk groups
10:00 am – 11:00 am Late Breaking Poster Session in Exhibit Hall
10:15 am – 11:00 am Product Theaters (2) in the Exhibit Hall
11:00 am – 11:10 am Award Presentations
11:15 am – 12:00 pm Evidence Generation to Inform Medical Decisions
Moderator: Mack Harrell, MD
Speaker: Robert Califf, MD


EDUCATIONAL OBJECTIVES:
  • Distinguish between high quality and poor quality medical evidence
  • Describe the Precision Medicine Initiative
  • Describe the reason for randomization in evidence generation
11:15 am – 12:00 pm Late Breaking Oral Presentations (Non-CME)
12:00 pm – 2:15 pm Exhibit Hall Open
12:15 pm – 2:00 pm AACE Annual Business Meeting Luncheon
2:15 pm – 3:15 pm MEET-THE-EXPERTS SESSION I
  Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


EDUCATIONAL OBJECTIVES:
  • Recognize secondary causes of male hypogonadism
  • Manage common secondary causes of male hypogonadism
  • Identify the limitations in diagnosing male hypogonadism
  Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


EDUCATIONAL OBJECTIVES:
  • Understand diagnostic criteria for acromegaly
  • Discuss medical options for acromegaly
  • Understand diagnostic criteria for Cushing’s disease
  Skin & Endocrine Disorders: Beyond the Usual
Moderator: Catalina Poiana, MD
Speaker: Michelle Tarbox, MD


EDUCATIONAL OBJECTIVES:
  • Identify dermatologic manifestations of diabetic disease.
  • Identify dermatologic side effects of medications used to treat diabetes.
  • Identify first and second line therapies for common skin diseases in patients with diabetes.
  Molecular Markers in Thyroid Nodule Evaluation
Moderator: Enrico Papini, MD
Speaker: Yuri Nikiforov, MD


EDUCATIONAL OBJECTIVES:
  • To provide an overview of molecular alterations in thyroid tumors
  • To discuss diagnostic utility of molecular markers for thyroid nodules and cancer
  • To discuss prognostic utility of molecular markers for risk stratification of thyroid cancer
  Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


EDUCATIONAL OBJECTIVES:
  • Identify psychosocial factors that may influence weight management in underserved populations
  • Understand how specific weight management strategies can be adapted for unique populations
  • Understand how to initiate discussions with patients from underserved populations about body weight and health risk
  Managing Transgender Youth
Moderator: Vin Tangpricha, MD
Speaker: Steve Rosenthal, MD


EDUCATIONAL OBJECTIVES:
  • Understand evidence for the biological determinants of gender identity
  • Understand current treatment models of transgender youth, including pubertal blockers and cross-sex hormones
  • Understand gaps in knowledge, barriers to care, and priorities for research
  SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD; Matthew Weir, MD


EDUCATIONAL OBJECTIVES:
  • To review the pathophysiology of T2DM
  • To review the treatment of T2DM based on its pathophysiology
  • To review the results of EDICT and the QATAR Study
EDUCATIONAL OBJECTIVES:
  • To understand the glomerular and systemic hemodynamic changes that occur with SGLT2 inhibitors
  • To appreciate the clinical significance of reduction in eGFR with SGT2 inhibitors
  • To consider opportunities for long term renal protection with SGLT2 inhibitors
3:15 pm – 3:30 pm Coffee Break
3:30 pm – 4:30 pm MEET-THE-EXPERTS SESSION II
  CGM in Pregnancy and Unique Populations
Moderator: Sandra Weber, MD
Speaker:Elizabeth Buschur, MD


EDUCATIONAL OBJECTIVES:
  • Identify ways in which CGM may benefit patients in the transition from pediatric to adult medical care
  • Identify how young women with diabetes may benefit from use of CGM preconception, during pregnancy, and postpartum
  • Identify benefits of CGM use in a patient with severe hypoglycemia
  Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker:Brian Casey,MD


EDUCATIONAL OBJECTIVES:
  • To review cases typically encountered by the obstetrician/endocrinologist during pregnancy
  • To review pertinent literature or data to guide management in these cases
  Clinical Cases of Endocrine Hypertension
Moderator: Kathleen Figaro, MD
Speaker: Richard Auchus, MD


EDUCATIONAL OBJECTIVES:
  • Analyze aldosterone/renin ratios in the context of medication and serum potassium
  • Interpret the results of adrenal vein sampling
  • List the medications that interfere with the evaluation of pheochromocytoma
  Approach to Hypogonadal Men: Management Strategies
Moderator: Craig Wierum, MD
Speaker: Michael Irwig, MD


EDUCATIONAL OBJECTIVES:
  • Recognize secondary causes of male hypogonadism
  • Manage common secondary causes of male hypogonadism
  • Identify the limitations in diagnosing male hypogonadism
  Challenging Pituitary Cases
Moderator: Adriana Ioachimescu, MD
Speaker: Anne Klibanski, MD


EDUCATIONAL OBJECTIVES:
  • Understand diagnostic criteria for acromegaly
  • Discuss medical options for acromegaly
  • Understand diagnostic criteria for Cushing’s disease
  Skin & Endocrine Disorders: Beyond the Usual
Moderator: Jimmy Aragon, MD
Speaker: Michelle Tarbox, MD


EDUCATIONAL OBJECTIVES:
  • Identify dermatologic manifestations of diabetic disease.
  • Identify dermatologic side effects of medications used to treat diabetes.
  • Identify first and second line therapies for common skin diseases in patients with diabetes.
  Molecular Markers in Thyroid Nodule Evaluation
Moderator: Jonathan Leffert, MD
Speaker: Yuri Nikiforov, MD


EDUCATIONAL OBJECTIVES:
  • To provide an overview of molecular alterations in thyroid tumors
  • To discuss diagnostic utility of molecular markers for thyroid nodules and cancer
  • To discuss prognostic utility of molecular markers for risk stratification of thyroid cancer
4:45 pm – 5:45 pm MEET-THE-EXPERTS SESSION III
  Weight Management in Underserved Populations
Moderator: Ved Gossain, MD
Speaker: Jamy Ard, MD


EDUCATIONAL OBJECTIVES:
  • Identify psychosocial factors that may influence weight management in underserved populations
  • Understand how specific weight management strategies can be adapted for unique populations
  • Understand how to initiate discussions with patients from underserved populations about body weight and health risk
  Managing Transgender Youth
Moderator: Ximena Lopez, MD
Speaker: Steve Rosenthal, MD


EDUCATIONAL OBJECTIVES:
  • Understand evidence for the biological determinants of gender identity
  • Understand current treatment models of transgender youth, including pubertal blockers and cross-sex hormones
  • Understand gaps in knowledge, barriers to care, and priorities for research
  SGLT2 Inhibitors Town Hall: Renal Microscope - Benefits and Concerns
Moderator: W. Timothy Garvey, MD
Speakers: Ralph DeFronzo, MD; Matthew Weir, MD


EDUCATIONAL OBJECTIVES:
  • To review the pathophysiology of T2DM
  • To review the treatment of T2DM based on its pathophysiology
  • To review the results of EDICT and the QATAR Study
EDUCATIONAL OBJECTIVES:
  • To understand the glomerular and systemic hemodynamic changes that occur with SGLT2 inhibitors
  • To appreciate the clinical significance of reduction in eGFR with SGT2 inhibitors
  • To consider opportunities for long term renal protection with SGLT2 inhibitors
  CGM in Pregnancy and Unique Populations
Moderator: Etie Moghissi, MD
Speaker:Liz Buschur, MD


EDUCATIONAL OBJECTIVES:
  • Identify ways in which CGM may benefit patients in the transition from pediatric to adult medical care
  • Identify how young women with diabetes may benefit from use of CGM preconception, during pregnancy, and postpartum
  • Identify benefits of CGM use in a patient with severe hypoglycemia
  Thyroid in Pregnancy and Newborn
Moderator: Leslie Eldeiry, MD
Speaker: Brian Casey, MD


EDUCATIONAL OBJECTIVES:
  • To review cases typically encountered by the obstetrician/endocrinologist during pregnancy
  • To review pertinent literature or data to guide management in these cases
  Clinical Cases of Endocrine Hypertension
Moderator: Kathleen Figaro, MD
Speaker: Richard Auchus, MD


EDUCATIONAL OBJECTIVES:
  • Analyze aldosterone/renin ratios in the context of medication and serum potassium
  • Interpret the results of adrenal vein sampling
  • List the medications that interfere with the evaluation of pheochromocytoma
  Learning from Legends
Moderator: Elliot Sternthal, MD
Speakers:Lewis Braverman, MD


EDUCATIONAL OBJECTIVES:
  • Understand the peripheral metabolism of thyroid hormones
  • Understand the role of iodine excess and deficiency on thyroid function
  • Understand goiter in art
6:30 pm ACE Convocation
7:30 pm President’s Gala

SUNDAY, MAY 7

7:00 am -11:00 am Attendee Registration
7:30 am -12:00 pm CME Station Hours
8:00 am – 8:15 am General Session Announcements
8:15 am – 8:45 am Multidisciplinary Approach to Endocrine Disease: MEN 2A
Moderator: Naifa Busaidy, MD
Panel: Naifa Busaidy, MD; David Terris, MD; Swati Mehrotra


EDUCATIONAL OBJECTIVES:
  • Understand the indications for surgical intervention in patients with MTC
  • Appreciate the options for extent of surgery, especially in the lateral neck
  • Learn about the considerations for managing co-existing parathyroid disease, especially in syndromic patients
  • Describe histopathologic alterations in endocrine organs in MEN 2A
8:45 am – 9:30 am Multidisciplinary Approach to Endocrine Disease: Hypoparathyroidism
Moderator: Naifa Busaidy, MD
Panel: Naifa Busaidy, MD; David Terris, MD; Swati Mehrotra


EDUCATIONAL OBJECTIVES:
  • Describe histopathologic alterations in parathyroid glands in hypoparathyroidism
9:30 am- 9:45 am Coffee Break
  President’s Announcements
9:45 am – 11:00 am Multidisciplinary Approach to Endocrine Disease: Thyroid Cancer - Alpha to Omega
Co-Moderators: Peter Singer, MD; Greg Randolph, MD
Panel: Steve Sherman, MD; Yuri Nikiforov, MD


EDUCATIONAL OBJECTIVES:
  • To define cancers that can be observed
  • To define the new entity of NIFTP
  • To understand current options for treatment of advanced cancer with distant metastasis